{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Aclacinomycin_B",
  "nciThesaurus": {
    "casRegistry": "57596-79-9",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "An antineoplastic oligosaccharide anthracycline antibiotic isolated from the bacterium Streptomyces galilaeus.  Aclacinomycin B intercalates into DNA and inhibits both the topoisomerase I and II enzymes, thereby inhibiting DNA replication and ultimately, interfering with RNA and protein synthesis.",
    "fdaUniiCode": "P8EJD9HI5K",
    "identifier": "C1861",
    "preferredName": "Aclacinomycin B",
    "semanticType": "Antibiotic",
    "subclassOf": [
      "C987"
    ],
    "synonyms": [
      "1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-((2,3,6-trideoxy-3-(dimethylamino)-alpha-L-lyxo-hexapyranosyl)oxy)-, methyl ester,(1R-(1-alpha,2-beta,4-beta))-",
      "ACLACINOMYCIN B",
      "Aclacinomycin B",
      "Aclarubicin B",
      "Antibiotic MA 144B1"
    ]
  }
}